News
12-17-2008, 04:36 AM
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, announced the launch in the European Union of Abraxane® Paclitaxel 5 mg/ml powder for suspension for infusion. Abraxane® is an albumin-bound nanoparticle formulation of paclitaxel.
More... (http://www.medicalnewstoday.com/articles/133195.php)
More... (http://www.medicalnewstoday.com/articles/133195.php)